TICKERNOMICS Sign up
Last Update: 2024-12-27 15:28:16
Annovis Bio Inc. ( ANVS ) https://www.annovisbio.com
5.16USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-73.62%
ANVS
SPY
32.66%
-72.68%
ANVS
SPY
108.59%
ANVS
0.00%
SPY
302.52%
ANVS
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
56.70
-12579.93
0.33
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-1.39
154.65
8.03
-23.69
0.00
516.68
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-341.59
-142.17
0.00
Other Earnings and Cash Flow Stats:
Annovis Bio Inc. ( ANVS ) Net Income TTM ($MM) is -40.94
Annovis Bio Inc. ( ANVS ) Operating Income TTM ($MM) is -30.40
Annovis Bio Inc. ( ANVS ) Owners' Earnings Annual ($MM) is 0.00
Annovis Bio Inc. ( ANVS ) Current Price to Owners' Earnings ratio is 0.00
Annovis Bio Inc. ( ANVS ) EBITDA TTM ($MM) is -30.40
Annovis Bio Inc. ( ANVS ) EBITDA Margin is 0.00%
Capital Allocation:
Annovis Bio Inc. ( ANVS ) has paid 0.00 dividends per share and bought back -3.963535 million shares in the past 12 months
Annovis Bio Inc. ( ANVS ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
Annovis Bio Inc. ( ANVS ) Interest-bearing Debt ($MM) as of last quarter is 0
Annovis Bio Inc. ( ANVS ) Annual Working Capital Investments ($MM) are -1
Annovis Bio Inc. ( ANVS ) Book Value ($MM) as of last quarter is 7
Annovis Bio Inc. ( ANVS ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
Annovis Bio Inc. ( ANVS ) has 12 million in cash on hand as of last quarter
Annovis Bio Inc. ( ANVS ) has 5 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Annovis Bio Inc. ( ANVS ) has 12 common shares outstanding as of last quarter
Annovis Bio Inc. ( ANVS ) has 0 million USD of preferred stock value
Academic Scores:
Annovis Bio Inc. ( ANVS ) Altman Z-Score is -12.76 as of last quarter
Annovis Bio Inc. ( ANVS ) Piotroski Score is 1.00 as of last quarter
Corporate Governance:
Annovis Bio Inc. ( ANVS ) largest shareholder is Bridgeway Capital Management, LLC owning 22100 shares at 0.11 ($MM) value
Maccecchini Maria-Luisa(President and CEO) Bought 32959 shares of Annovis Bio Inc. ( ANVS ) for the amount of $4614.26 on 2022-01-14
20.40% of Annovis Bio Inc. ( ANVS ) is held by insiders, and 8.83% is held by institutions
Annovis Bio Inc. ( ANVS ) went public on 2010-02-12
Other Annovis Bio Inc. ( ANVS ) financial metrics:
FCF:-22.98
Unlevered Free Cash Flow:-38.31
EPS:-3.90
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-715.68
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Annovis Bio Inc. ( ANVS ) :
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.